NCT01705548
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with brain metastasis less than 3 cm or greater than 6 cm; Patients with metastases to brain stem, midbrain, pons, or medulla or within 5 mm of the optic apparatus (optic nerves & chiasm)
https://ClinicalTrials.gov/show/NCT01705548